Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin cell turnover, also called epidermal turnover or skin regeneration, is a cyclical process by which the epidermis sheds dead, terminally differentiated cells from the stratum corneum and replaces them with new cells generated by basal epidermal stem cells. This tightly regulated process relies on proliferation, differentiation, and apoptosis of keratinocytes, orchestrated by numerous signaling pathways such as Wnt/β-catenin, Notch, p53, and growth factors. Proper skin cell turnover maintains the skin’s barrier function, appearance, and resilience; disruptions can lead to disease. While drugs like retinoids and hydroxy acids can modulate turnover for therapeutic or cosmetic effect, skin cell turnover itself is not a molecular drug target but rather the outcome of complex cellular regulation.
Stimulation of keratinocyte proliferation, promotion of differentiation, induction of exfoliation (removal of stratum corneum), and modulation of apoptosis pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin cell turnover.